Oxocrebanine inhibits the proliferation of hepatocellular carcinoma cells by promoting apoptosis and autophagy

Figure 5 Hep3B2. 1-7 cell viability and proliferation rate measured by MTT assay and BrdU test. A: Viability of cells treated with oxocrebanine and 3-MA as demonstrated by MTT assat; B: Proliferation rate of cells treated with oxocrebanine and 3-MA. Data are shown as the mean ± SD. ^aP < 0.01 vs control; ^bP < 0.01 vs oxocrebanine group (n = 3).